HomePeopleSuryakant Niranjan Chiplunkar
Profile Picture

Suryakant Niranjan Chiplunkar Profile

Suryakant Niranjan Chiplunkar, Director and Designated Partner, with 3 companies.

About Suryakant Niranjan Chiplunkar

Suryakant Niranjan Chiplunkar has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Medifusion Healthcare Private Limited and Artifaiv Healthcare Llp. Formerly with 1 company, such as Mecviz Endoscopy (I) Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.

Current Companies

2

Past Companies

1

Total Affiliations

3

Oldest Company Age

9

Companies Associated with Suryakant Niranjan Chiplunkar

Current Companies

Previous Companies

Explore Director's current and past company associations— Uncover their professional journey today!

Frequently Asked Questions

Who is Suryakant Niranjan Chiplunkar?
Suryakant Niranjan Chiplunkar has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Medifusion Healthcare Private Limited and Artifaiv Healthcare Llp. Formerly with 1 company, such as Mecviz Endoscopy (I) Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
What is Suryakant Niranjan Chiplunkar's role in current companies?
Suryakant Niranjan Chiplunkar is associated with 2 companies as Director and Designated Partner.
What industries does Suryakant Niranjan Chiplunkar specialize in?
Suryakant Niranjan Chiplunkar has expertise in Healthcare, General Business.
How many years of experience does Suryakant Niranjan Chiplunkar have?
Suryakant Niranjan Chiplunkar has 13 years in corporate governance.
Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial